Boston Scientific Recalls CLEARSIGN II Amplifiers Due to ECG Signal Interference
Boston Scientific is recalling 43 CLEARSIGN II Amplifiers because blood pressure channel usage can cause ECG signals to become uninterpretable.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a medical device where a functional defect can lead to uninterpretable diagnostic signals, representing a risk of harm where injury has not yet been reported.
Plain-English summary
Boston Scientific Corporation is recalling 43 units of the CLEARSIGN II Amplifier for the LABSYSTEM PRO EP Recording System. The affected devices use firmware version 2.08 and are available in 40, 80, 120, and 160-channel configurations. The recall covers specific catalog and lot numbers distributed worldwide to countries including Austria, Belgium, France, Germany, Great Britain, Greece, Italy, Netherlands, Poland, Romania, South Africa, Spain, Switzerland, and Turkey. There was no distribution in the United States.
The recall was initiated after Boston Scientific received complaints indicating that using the blood pressure channels on the amplifier causes the surface Electrocardiogram (ECG) channels to become over-written. This results in the ECG signal appearing shifted from baseline on the system's output screen, which may manifest as an uninterpretable ECG signal in the affected channel.
The CLEARSIGN II Amplifier is intended to amplify and condition electrocardiographic signals of biologic origin and pressure transducer input, transmitting this information to a host computer for recording and display. Users of the affected devices should stop using the blood pressure channels to prevent potential ECG signal interference.
The recalled product
- Product
- CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System, 120 channels, using firmware version 2.08. The channel numbers in the amplifier are as follows: Material number: H30120020210 - 40 Channel CLEARSIGN II Amplifier, catalog number 2002021; Material number: H3012002022
- Manufacturer
- Boston Scientific Corporation
- Affected units
- 43
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Catalog number 2002021: lot numbers: EPYL0080
- EPYL0118
- EPZA0061
- EPZA0072
- EPZA0073
- EPZA0074
- EPZB0043
- EPZC0019
- EPZC0026
- EPZC0027
- Catalog number 2002022: lot numbers: EPYL0031
- EPYL0032
- EPYL0033
- EPYL0034
- EPYL0035
- EPYL0036
- EPYL0037
- EPYL0038
- EPYL0039
- EPZA0062
Distribution
Distribution scope not specified by the agency.
Related recalls
Same manufacturer · Boston Scientific Corporation
See all →- HighBoston Scientific Recalls OverStitch Suture Cinch Devices for Deployment Failure
FDA (Devices) · 2026-08-26
- HighBoston Scientific ENROUTE Transcarotid Neuroprotection System Plus Recall
FDA (Devices) · 2026-08-26
- HighBoston Scientific ENROUTE Transcarotid Neuroprotection System Recall for Tip Separation
FDA (Devices) · 2026-08-26
- HighBoston Scientific Recalls Suture Cinch Endoscopic Tissue Approximation Devices
FDA (Devices) · 2026-08-26
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12
Same hazard · signal interference
See all →- HighMedtronic Insertable Cardiac Monitor May Fail to Record Heart Rhythms
FDA (Devices) · 2023-12-06
- HighGE Healthcare Recalls Dash Patient Monitors Due to ECG Noise
FDA (Devices) · 2014-01-29
- ModerateOrthosensor Recalls Knee Trial Software Due to Signal Interference
FDA (Devices) · 2012-10-31